<DOC>
	<DOCNO>NCT00830895</DOCNO>
	<brief_summary>To assess efficacy safety RAD001 ( everolimus ) non-clear cell renal cell carcinoma</brief_summary>
	<brief_title>RAD001 Non-clear Cell Renal Cell Carcinoma ( RCC )</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>1 . Histologically cytologically confirm nonclear cell renal cell carcinoma ( papillary , chromophobe , collect duct , oncocytic subtype , sarcomatoid mainly ) 2 . Subjects metastatic legion 3 . Subjects age 18 year old 4 . Subjects whose ECOG performance status 0 1 5 . Subjects laboratory value ; Hematology Neutrophil &gt; = 1.5 x 109/L Platelet &gt; = 75 x 109/L Hemoglobin &gt; = 9 g/dL Liver function test Total bilirubin ≤ 1.5 xULN AST , ALT ≤ 2.5 xULN Alkaline phosphatase ≤ 2.5 xULN Renal function test Creatinine clearance &gt; = 30 mL/min 6 . Subjects understand provide write informed consent 1 . Subjects administer mTOR inhibitor 2 . Pregnant nursing woman , woman childbearing potential must use appropriate contraception study period result pregnancy test perform within 14 day enrollment must negative 3 . Subjects participate clinical study use study medication within 30 day randomization 4 . Subjects clinically uncontrolled central nervous system ( CNS ) metastasis 5 . Subjects life expectancy le 3 month 6 . Subjects interstitial pulmonary disease 7 . Subjects whose QTc interval prolong ( QTc &gt; 450 msec male &gt; 470 msec female ) 8 . Other serious disease medical condition Heart disease unstable despite treatment History myocardial infarction within six month study History serious neurological psychological disorder include dementia seizure Active peptic ulcer control drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Renal cell carcinoma</keyword>
	<keyword>Non-clear cell</keyword>
	<keyword>RAD001</keyword>
	<keyword>Metastatic , non-clear cell , renal cell carcinoma</keyword>
</DOC>